Show
Sort by
-
- Journal Article
- A1
- open access
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort
-
- Journal Article
- A1
- open access
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
-
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial
-
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
-
- Journal Article
- A1
- open access
Developing and evaluating a participatory arts programme for cancer patients and their caregivers
-
- Miscellaneous
- open access
The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases
-
- Journal Article
- A1
- open access
Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials : a case-control study
-
The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment
-
Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment
-
The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients